Announcement of Dashenlin Pharmaceutical Group Co., Ltd. on the implementation of related transactions in 2023 and the forecast of daily related transactions in 2024

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.